
Burning Rock Biotech Limited BNR
$ 9.12
4.95%
Quarterly report 2025-Q4
added 05-23-2026
Burning Rock Biotech Limited Cash Conversion Cycle 2011-2026 | BNR
Annual Cash Conversion Cycle Burning Rock Biotech Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 146 | 183 | 217 | 204 | 183 | 198 | 120 | - | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 217 | 120 | 179 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | ||
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-2.46 K | $ 5.76 | 11.41 % | $ 7.66 M | ||
|
Castle Biosciences
CSTL
|
31.6 | $ 21.68 | 6.33 % | $ 628 M | ||
|
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
2.11 | - | -61.36 % | $ 2.46 M | ||
|
Fulgent Genetics
FLGT
|
51.8 | $ 19.86 | 9.48 % | $ 611 M | ||
|
Guardant Health
GH
|
79.6 | $ 133.0 | 4.7 % | $ 16.7 B | ||
|
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
52.5 | $ 152.75 | 6.15 % | $ 12 B | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 23.0 | 3.09 % | $ 1.23 B | ||
|
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | ||
|
Illumina
ILMN
|
147 | $ 167.87 | -1.79 % | $ 26 B | ||
|
Interpace Biosciences
IDXG
|
62.9 | $ 1.79 | 2.29 % | $ 7.92 M | ||
|
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 178.83 | 0.75 % | $ 24.3 B | ||
|
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
97.3 | $ 102.5 | 2.24 % | $ 6.92 B | ||
|
NeoGenomics
NEO
|
82.4 | $ 11.47 | 13.12 % | $ 1.47 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 186.15 | 3.39 % | $ 9.23 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
Natera
NTRA
|
48.3 | $ 225.67 | 6.52 % | $ 30.9 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 457.47 | 1.48 % | $ 13.2 B | ||
|
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 19.55 | 2.68 % | $ 438 M | ||
|
Myriad Genetics
MYGN
|
49.3 | $ 4.76 | 8.07 % | $ 441 M | ||
|
Personalis
PSNL
|
-1.89 | $ 12.38 | 14.84 % | $ 1.1 B | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 26.0 | 2.52 % | $ 24.7 B | ||
|
Senseonics Holdings
SENS
|
36.1 | $ 7.03 | 4.61 % | $ 293 M | ||
|
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
-398 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
172 | $ 2.15 | 1.9 % | $ 4.94 M | ||
|
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 260.96 | 0.8 % | $ 21.7 B | ||
|
Twist Bioscience Corporation
TWST
|
83.6 | $ 74.75 | 3.35 % | $ 4.47 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 480.69 | 1.4 % | $ 181 B | ||
|
Trinity Biotech plc
TRIB
|
136 | $ 0.68 | -2.84 % | $ 244 M | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
150 | $ 9.13 | 3.58 % | $ 1.98 B | ||
|
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 196.31 | 1.29 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | ||
|
Waters Corporation
WAT
|
731 | $ 377.4 | -0.61 % | $ 22.5 B |